Skip to main content
. 2016 Sep 28;17:473. doi: 10.1186/s13063-016-1595-7

Fig. 2.

Fig. 2

Citation rates of non-alteplase (non-tPA) thrombolytic trials for acute stroke. Cumulative citation counts over time for positive (solid lines), neutral dashed lines), and negative (dotted lines) randomized controlled trials of thrombolytic agents other than tPA for acute ischemic stroke

HHS Vulnerability Disclosure